Jenny Cartwright shared this message from the Children’s Cause Cancer Advocacy Group
The National Cancer Institute
will hold a meeting about pediatric cancer drug development
Friday, Feb. 21
Dear Childhood Cancer Advocate,
There will be a meeting next week at the National Cancer Institute (NCI) dedicated to pediatric cancer drug development.
The NCI will hold its 64th Meeting of the Director’s Consumer Liaison Group (DCLG) on Friday, February 21, 2014 from 9:30 a.m. to 4:00 p.m. on the National Institutes of Health (NIH) Campus in Bethesda, MD.
The panels will discuss the Potential Role of the Pediatric Cancer Advocacy Community in Reducing Barriers to Drug Development as well as Advancing Pediatric Cancer Research Through Advocacy.
The meeting will focus on barriers to drug development in pediatric cancer research and will include participants from the pediatric cancer advocacy community, as well as private and public sector presenters.
If you are interested in attending in person, please RSVP by emailing Nichelle Lewis at: email@example.com or by calling (301) 594-9896. To participate via the webcast visit: http://videocast.nih.gov on Feb 21 to watch the meeting.
We hope you can participate in this special opportunity to hear about the state of pediatric cancer research and what you can do to help.